Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.

Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB.

Gynecol Oncol. 2009 Mar;112(3):594-600. doi: 10.1016/j.ygyno.2008.11.039. Epub 2009 Jan 13.

PMID:
19141360
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.

Robson M, Hensley M, Barakat R, Brown C, Chi D, Poynor E, Offit K.

Gynecol Oncol. 2003 May;89(2):281-7.

PMID:
12713992
[PubMed - indexed for MEDLINE]
3.

Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer.

Michelsen TM, Dørum A, Tropé CG, Fosså SD, Dahl AA.

Int J Gynecol Cancer. 2009 Aug;19(6):1029-36. doi: 10.1111/IGC.0b013e3181a83cd5.

PMID:
19820364
[PubMed - indexed for MEDLINE]
4.

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.

Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF, Gaarenstroom KN, Mourits MJ, Verheijen RH, van Dorst EB, van der Putten H, van der Velden K, Boonstra H, Aaronson NK.

J Clin Oncol. 2005 Oct 1;23(28):6890-8. Epub 2005 Aug 29.

PMID:
16129845
[PubMed - indexed for MEDLINE]
5.

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.

Greene MH, Piedmonte M, Alberts D, Gail M, Hensley M, Miner Z, Mai PL, Loud J, Rodriguez G, Basil J, Boggess J, Schwartz PE, Kelley JL, Wakeley KE, Minasian L, Skates S.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):594-604. doi: 10.1158/1055-9965.EPI-07-2703.

PMID:
18349277
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.

Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Hollenstein J, Massuger LF, Gaarenstroom KN, Mourits MJ, Verheijen RH, van Dorst EB, van der Putten H, van der Velden K, Boonstra H, Aaronson NK.

J Clin Oncol. 2006 Aug 1;24(22):3576-82.

PMID:
16877724
[PubMed - indexed for MEDLINE]
7.

Factors associated with altered long-term well-being after prophylactic salpingo-oophorectomy among women at increased hereditary risk for breast and ovarian cancer.

Touboul C, Uzan C, Ichanté JL, Caron O, Dunant A, Dauchy S, Gouy S, de Paillerets BB, Morice P, Delaloge S.

Oncologist. 2011;16(9):1250-7. doi: 10.1634/theoncologist.2010-0336. Epub 2011 Jul 17.

PMID:
21765195
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer.

Fry A, Busby-Earle C, Rush R, Cull A.

Psychooncology. 2001 May-Jun;10(3):231-41.

PMID:
11351375
[PubMed - indexed for MEDLINE]
9.

The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation.

Finch A, Metcalfe KA, Chiang J, Elit L, McLaughlin J, Springate C, Esplen MJ, Demsky R, Murphy J, Rosen B, Narod SA.

Psychooncology. 2013 Jan;22(1):212-9. doi: 10.1002/pon.2041. Epub 2011 Sep 13.

PMID:
21913283
[PubMed - indexed for MEDLINE]
10.

Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.

Hensley ML, Robson ME, Kauff ND, Korytowsky B, Castiel M, Ostroff J, Hurley K, Hann LE, Colon J, Spriggs D.

Gynecol Oncol. 2003 Jun;89(3):440-6.

PMID:
12798709
[PubMed - indexed for MEDLINE]
11.

Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer.

Meiser B, Price MA, Butow PN, Karatas J, Wilson J, Heiniger L, Baylock B, Charles M, McLachlan SA, Phillips KA.

Fam Cancer. 2013 Mar;12(1):101-9. doi: 10.1007/s10689-012-9585-8.

PMID:
23203849
[PubMed - indexed for MEDLINE]
12.

Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.

Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ.

Am J Surg Pathol. 2009 Aug;33(8):1125-36. doi: 10.1097/PAS.0b013e31819e986a.

PMID:
19440148
[PubMed - indexed for MEDLINE]
13.

Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer.

Elit L, Esplen MJ, Butler K, Narod S.

Fam Cancer. 2001;1(3-4):149-56.

PMID:
14574171
[PubMed - indexed for MEDLINE]
14.

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.

Domchek SM, Friebel TM, Garber JE, Isaacs C, Matloff E, Eeles R, Evans DG, Rubinstein W, Singer CF, Rubin S, Lynch HT, Daly MB, Weitzel J, Ganz PA, Pichert G, Olopade OI, Tomlinson G, Tung N, Blum JL, Couch F, Rebbeck TR.

Breast Cancer Res Treat. 2010 Nov;124(1):195-203. doi: 10.1007/s10549-010-0799-x. Epub 2010 Feb 24.

PMID:
20180014
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.

Benshushan A, Rojansky N, Chaviv M, Arbel-Alon S, Benmeir A, Imbar T, Brzezinski A.

Climacteric. 2009 Oct;12(5):404-9. doi: 10.1080/13697130902780846.

PMID:
19479488
[PubMed - indexed for MEDLINE]
16.

Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.

Manchanda R, Burnell M, Abdelraheim A, Johnson M, Sharma A, Benjamin E, Brunell C, Saridogan E, Gessler S, Oram D, Side L, Rosenthal AN, Jacobs I, Menon U.

BJOG. 2012 Apr;119(5):527-36. doi: 10.1111/j.1471-0528.2011.03257.x. Epub 2012 Jan 20.

PMID:
22260402
[PubMed - indexed for MEDLINE]
17.

Oophorectomy in premenopausal women: health-related quality of life and sexual functioning.

Teplin V, Vittinghoff E, Lin F, Learman LA, Richter HE, Kuppermann M.

Obstet Gynecol. 2007 Feb;109(2 Pt 1):347-54.

PMID:
17267835
[PubMed - indexed for MEDLINE]
18.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
[PubMed - indexed for MEDLINE]
Free Article
19.

Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing.

Mannis GN, Fehniger JE, Creasman JS, Jacoby VL, Beattie MS.

JAMA Intern Med. 2013 Jan 28;173(2):96-103. doi: 10.1001/2013.jamainternmed.962.

PMID:
23247828
[PubMed - indexed for MEDLINE]
20.

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.

Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM.

Am J Obstet Gynecol. 2006 Jun;194(6):1702-9.

PMID:
16731090
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk